pharma · Solid Tumor
Qingdao University
Qingdao University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Solid Tumor. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity f
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
HS-IT101 Injection
Phase 1 · small molecule · Solid Tumor
HS-IT101 Injection for Solid Tumor is a Phase 1 program (small_molecule) at Qingdao University with 1 ClinicalTrials.gov record(s).
Internal code HS-IT101ST01-I
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Qingdao University
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Solid Tumor
- Status
- active
- Trials
- 1